Anthony Partridge

Anthony Partridge is a Senior Director at Genentech, where they focus on in vitro pharmacology and targeted degradation. With extensive experience in the pharmaceutical industry, they have previously held significant roles at several organizations, including Senior Principal Scientist at Merck and Vice President at Roivant Sciences. Anthony earned a PhD in Biochemistry from the University of Toronto and has contributed broadly to drug discovery, leading teams and pioneering innovative research approaches throughout their career. They also have experience as a Post-Doctoral Fellow at esteemed institutions, including the University of California San Diego and The Scripps Research Institute.